Soleno Therapeutics, Inc. · NASDAQ:SLNO

Avoro Capital Advisors LLC's stake in Soleno Therapeutics, Inc. fell to 4.45% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Avoro Capital Advisors LLC's stake in Soleno Therapeutics, Inc. fell to 4.45%, 2,300,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
4.45%
Shares
2,300,000
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC4.45%2,300,000
Behzad Aghazadeh4.45%2,300,000

Source

View original at SEC

Related